Management of venous thromboembolism in patients with primary and metastatic brain tumors

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
David E GerberMichael B Streiff

Abstract

Venous thromboembolism occurs commonly throughout the clinical course of patients with brain tumors. A number of hemostatic and clinical factors contribute to this hypercoagulable state. Concern over the possibility of intracranial bleeding has limited the use of anticoagulation in this population. However, mechanical approaches such as vena cava filters have high complication and treatment failure rates in patients with intracranial malignancies. In addition, the available data suggest that anticoagulation can be used safely and effectively in most of these patients. Patients with thrombocytopenia, recent neurosurgery, and tumor types prone to bleeding require special consideration. When intracranial hemorrhage does occur, it is often due to overanticoagulation, requiring prompt anticoagulation reversal and neurosurgical consultation.

References

Jul 2, 1975·Journal of Neurology·M C Kayser-Gatchalian, K Kayser
Sep 1, 1978·Journal of Neurosurgery·D CerratoF Fiacchino
Jul 1, 1977·Journal of Neurosurgery·H G BarnettR C Llewellyn
Oct 1, 1992·Journal of Neuro-oncology·R SawayaH Nishiyama
Oct 1, 1992·Journal of Neuro-oncology·R Sawaya, P Glas-Greenwalt
Oct 1, 1992·Acta Anaesthesiologica Scandinavica·D BergqvistT Mätzsch
Sep 1, 1992·American Journal of Surgery·A J ComerotaJ V White
Nov 1, 1989·Southern Medical Journal·J H MuchmoreM D Kerstein
Dec 1, 1987·Journal of Neurosurgery·D KondziolkaH Schutz
Mar 1, 1985·Computerized Radiology : Official Journal of the Computerized Tomography Society·L A Weisberg
Mar 1, 1983·Annals of Neurology·R L Ruff, J B Posner
Feb 1, 1980·Neurosurgery·J B Valladares, J Hankinson
Jan 1, 1994·Journal of Neuro-oncology·L K Norris, S A Grossman
Jan 1, 1994·Journal of Neuro-oncology·R E Sawaya, B L Ligon
Jan 1, 1994·Journal of Neuro-oncology·L Thoron, E Arbit
Apr 1, 1994·Mayo Clinic Proceedings·J F QuevedoJ R O'Fallon
Jun 1, 1994·Annals of Internal Medicine·E M Hylek, D E Singer
May 1, 1994·Progress in Cardiovascular Diseases·J S Alpert, J E Dalen
Mar 1, 1994·Neurosurgery·T J IbertiJ H Rand
Jan 15, 1994·Cancer·D Schiff, L M DeAngelis
Apr 1, 1993·Neurosurgery·V Laohaprasit, M R Mayberg
Jan 1, 1997·Surgical Neurology·M HeesenK J Matthes
Apr 1, 1997·Mayo Clinic Proceedings·E F Wijdicks, J P Scott
Dec 9, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A A BrandesM V Fiorentino
Apr 29, 1998·The New England Journal of Medicine·H T SørensenG L Nielsen
Jul 11, 1998·Journal of the American College of Surgeons·E E CornwellD Demetriades

❮ Previous
Next ❯

Citations

Aug 2, 2008·The New England Journal of Medicine·Patrick Y Wen, Santosh Kesari
Nov 1, 2012·Neuro-oncology·James R Perry
Aug 8, 2009·American Journal of Clinical Oncology·Jack E Ansell
May 6, 2010·Molecular Cancer Research : MCR·Marcin WysoczynskiMariusz Z Ratajczak
Mar 1, 2007·Neuro-oncology·Ralph SimanekChristine Marosi
Apr 17, 2007·Journal of Neurosurgery·E Antonio Chiocca, Judith A Schwartzbaum
Jan 1, 2013·CNS Oncology·Radhika Dasararaju, Amitkumar Mehta
Sep 25, 2014·The New England Journal of Medicine·Jean M Connors
Dec 15, 2015·Thrombosis Research·Natasha Catherine EdwinAlok A Khorana
Jul 17, 2012·Hematology/oncology Clinics of North America·Jill LacyJames B Yu
Sep 10, 2011·Revue neurologique·L TaillandierE Le Rhun
Oct 5, 2010·Neuro-Chirurgie·P Paquis, P Menei
May 22, 2010·Hematology/oncology Clinics of North America·Thomas G DeLoughery
Aug 4, 2009·Emergency Medicine Clinics of North America·Thomas G DeLoughery
Sep 12, 2009·Thrombosis Research·Davide ImbertiUNKNOWN Italian Society for Thrombosis and Haemostasis
Apr 9, 2008·Pathologie-biologie·D Farge-BancelP Debourdeau
Oct 30, 2007·Neurologic Clinics·Jan DrappatzPatrick Y Wen
Jul 5, 2007·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·José Rafael RomeroViken L Babikian
Jul 26, 2011·Annals of Neurology·Matthias PreusserRoger Stupp
Aug 4, 2011·Journal of Thrombosis and Haemostasis : JTH·G Agnelli, M Verso
Nov 17, 2009·Journal of Thrombosis and Haemostasis : JTH·E O JenkinsN S Key
Jan 27, 2015·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Yasuyuki ItoYukio Ando
Jan 25, 2011·Expert Opinion on Pharmacotherapy·Javier Trujillo-Santos, Manuel Monreal
Jul 6, 2015·Current Treatment Options in Oncology·Jeffrey J Raizer, Karan S Dixit
May 17, 2013·Seminars in Hematology·Axel Matzdorff, Juerg-Hans Beer
Jun 15, 2013·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Thorleif EtgenLukas Gsottschneider
Nov 2, 2014·Neuro-oncology·David SchiffPatrick Y Wen
Dec 24, 2014·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Timothy R SmithJames P Chandler
Nov 29, 2011·Clinical Journal of Oncology Nursing·Judy Lima
Aug 29, 2007·Oncology Nursing Forum·Nancy Eisenson
Dec 18, 2009·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Felice Vito VitaleFrancesco Ferraù
Sep 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael B Streiff
Jan 14, 2011·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Felice Vito VitaleFrancesco Ferraù
Sep 21, 2011·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Amber H DiazJeffrey A Gilreath
Apr 4, 2008·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Myra F BarginearDaniel R Budman
Jul 27, 2011·American Journal of Physical Medicine & Rehabilitation·Mary Vargo
Nov 20, 2018·Journal of Thrombosis and Haemostasis : JTH·B J CarneyJ I Zwicker
Sep 19, 2008·Pediatric Blood & Cancer·Uma AthaleAnthony K C Chan
Jun 21, 2015·World Journal of Surgical Oncology·Jihane KhalilNoureddine Benjaafar
Jan 1, 2007·Journal of Radiotherapy in Practice·David E GerberLawrence Kleinberg
Jun 28, 2011·Journal of Neuro-oncology·Andrew D NordenPatrick Y Wen
Apr 6, 2012·Expert Review of Hematology·Caroline PiatekHoward A Liebman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Pulmonary Medicine
D C Walsh, A K Kakkar
The New England Journal of Medicine
Agnes Y Y LeeRandomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Veno
© 2021 Meta ULC. All rights reserved